Kolon Life Science Inc.

KOSDAQ:A102940 Stock Report

Market Cap: ₩252.2b

Kolon Life Science Management

Management criteria checks 0/4

We currently do not have sufficient information about the CEO.

Key information

Sun Jin Kim

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenure1.1yrs
CEO ownershipn/a
Management average tenureno data
Board average tenureno data

Recent management updates

Recent updates

Risks Still Elevated At These Prices As Kolon Life Science Inc. (KOSDAQ:102940) Shares Dive 26%

Mar 02
Risks Still Elevated At These Prices As Kolon Life Science Inc. (KOSDAQ:102940) Shares Dive 26%

We Think Kolon Life Science (KOSDAQ:102940) Has A Fair Chunk Of Debt

Mar 12
We Think Kolon Life Science (KOSDAQ:102940) Has A Fair Chunk Of Debt

A Look At Kolon Life Science's (KOSDAQ:102940) Share Price Returns

Jan 18
A Look At Kolon Life Science's (KOSDAQ:102940) Share Price Returns

Kolon Life Science (KOSDAQ:102940) Is Carrying A Fair Bit Of Debt

Nov 26
Kolon Life Science (KOSDAQ:102940) Is Carrying A Fair Bit Of Debt

CEO

Sun Jin Kim

1.1yrs

Tenure

Mr. Sun Jin Kim, M.D, Ph D, is Chief Executive Officer at Kolon Life Science Inc. since April 2023. He has been the Chief Medical Officer at Kolon TissueGene, Inc. since June 2021.He had been an Outside D...


Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.